ExodusPoint Capital Management LP Purchases Shares of 152,756 Integer Holdings Co. (NYSE:ITGR)

ExodusPoint Capital Management LP acquired a new stake in Integer Holdings Co. (NYSE:ITGR) in the 2nd quarter, Holdings Channel reports. The fund acquired 152,756 shares of the medical equipment provider’s stock, valued at approximately $13,536,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. BlackRock Inc. boosted its holdings in shares of Integer by 0.6% in the first quarter. BlackRock Inc. now owns 6,018,773 shares of the medical equipment provider’s stock valued at $484,933,000 after acquiring an additional 38,664 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Integer by 1.5% during the third quarter. Vanguard Group Inc. now owns 3,738,440 shares of the medical equipment provider’s stock worth $232,643,000 after buying an additional 54,575 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Integer by 1.4% during the first quarter. Dimensional Fund Advisors LP now owns 2,146,916 shares of the medical equipment provider’s stock worth $166,383,000 after buying an additional 30,583 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in Integer by 5.4% during the second quarter. Victory Capital Management Inc. now owns 1,498,651 shares of the medical equipment provider’s stock worth $132,795,000 after buying an additional 76,253 shares in the last quarter. Finally, State Street Corp boosted its holdings in Integer by 0.9% during the first quarter. State Street Corp now owns 1,334,832 shares of the medical equipment provider’s stock worth $103,449,000 after buying an additional 12,106 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Integer news, Director Donald J. Spence sold 6,500 shares of the stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $82.32, for a total value of $535,080.00. Following the completion of the sale, the director now owns 18,781 shares in the company, valued at approximately $1,546,051.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.84% of the company’s stock.

Integer Stock Up 0.7 %

Shares of NYSE:ITGR opened at $89.57 on Tuesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.86 and a current ratio of 3.00. The company has a market cap of $2.99 billion, a PE ratio of 36.56, a price-to-earnings-growth ratio of 1.22 and a beta of 1.10. Integer Holdings Co. has a 52 week low of $61.85 and a 52 week high of $96.17. The firm has a 50 day simple moving average of $80.36 and a 200 day simple moving average of $83.17.

Integer (NYSE:ITGR) last released its earnings results on Thursday, October 26th. The medical equipment provider reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.22. Integer had a net margin of 5.30% and a return on equity of 10.27%. The company had revenue of $404.69 million during the quarter, compared to the consensus estimate of $376.70 million. During the same quarter in the prior year, the firm earned $0.95 EPS. The company’s revenue was up 18.1% compared to the same quarter last year. As a group, research analysts expect that Integer Holdings Co. will post 4.59 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. TheStreet upgraded shares of Integer from a “c+” rating to a “b” rating in a report on Thursday, July 27th. Wells Fargo & Company raised their target price on shares of Integer from $87.00 to $94.00 and gave the stock an “equal weight” rating in a report on Friday, July 28th. KeyCorp raised their target price on shares of Integer from $96.00 to $105.00 and gave the stock an “overweight” rating in a report on Friday, July 28th. Benchmark upped their price target on shares of Integer from $90.00 to $105.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Finally, StockNews.com started coverage on shares of Integer in a research report on Thursday, October 5th. They issued a “hold” rating for the company. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $93.83.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.